Leukotriene receptor antagonists can specifically inhibit CysLT1 receptors in the airway, thereby improving airway inflammation and effectively controlling asthma.
It is an organic compound with the formula C35H35ClNNaO3S.
It is suitable for the prevention and long-term treatment of asthma in adults and children, including the prevention of daytime and nighttime asthma symptoms, the treatment of aspirin-sensitive asthma patients, and the prevention of exercise-induced bronchoconstriction.
/
1.Patients who are allergic to any component of this product is prohibited.